Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Tranexamic Acid and Topical Hydroquinone for Melasma
NCT03751163Phase 3Completed
- Sponsor
- Faculty of Medicine, Universitas Indonesia
- Start
- Mar 2016
- Primary completion
- Apr 2017
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in melasma comparing Tranexamic Acid + Hydroquinone with Placebo + Hydroquinone (2 arms). Primary endpoint: modified Melasma Area and Severity Index at 12 weeks. Started Mar 2016; status: completed.
02
Drugs
tranexamic acid
03
Conditions
melasma
Beyond the preview
Go deeper on NCT03751163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03751163.